 
- 积分
- 416
- 威望
- 416
- 包包
- 1859
|
HIGHLIGHTS OF PRESCRIBING
$ ~( e6 A' m- g$ a, ^# }' }INFORMATION
0 ~" e. v2 z) PThese highlights do not include all of the
* Q1 q" i9 ~1 F0 }1 e& W" rinformation needed to use PROVENGE®
* b5 R: e' @9 g0 V& I0 `( C* z& H# | ! |: D) \% {' n
(sipuleucel - T) safely and effectively. See f ull : i4 V4 ~1 G3 j; p! d
prescribing information for PROVENGE.
5 K( g" Z. L5 k/ @PROVENGE® (sipuleucel - T)
" f% b U( J) r# u- J# _Suspension for Intravenous Infusion 1 w9 D, n7 o$ \# d6 Z( c) M9 z
Initial U.S. Approval: 2010
) Y" U# |' s- B# A- - - - - - - INDICATIONS AND USAGE - - - - - - |
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|